BPG is committed to discovery and dissemination of knowledge
Featured Articles
Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease
Browse: 219   Download: 561   Issue Date: 2024-10-21
Calcineurin inhibitors-related posterior reversible encephalopathy syndrome in liver transplant recipients: Three case reports and review of literature
Browse: 164   Download: 621   Issue Date: 2024-09-23
Hepatic ectopic pregnancy with hemorrhage secondary diaphragmatic adhesion: A case report
Browse: 189   Download: 611   Issue Date: 2024-09-23
Immune remodulation in pediatric inherited metabolic liver diseases
Browse: 180   Download: 529   Issue Date: 2024-09-23
Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential
Browse: 179   Download: 621   Issue Date: 2024-09-23
Kick-start for metabolomics in liver disease
Browse: 178   Download: 510   Issue Date: 2024-09-23
Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
Browse: 205   Download: 577   Issue Date: 2024-08-22
Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
Browse: 268   Download: 628   Issue Date: 2024-08-22
Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?
Browse: 304   Download: 548   Issue Date: 2024-08-22
Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
Browse: 232   Download: 437   Issue Date: 2024-08-22
Rocahepevirus ratti: An underrecognised cause of acute hepatitis
Browse: 176   Download: 461   Issue Date: 2024-08-22
Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
Browse: 329   Download: 723   Issue Date: 2024-07-26
Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
Browse: 323   Download: 828   Issue Date: 2024-07-26
Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
Browse: 314   Download: 629   Issue Date: 2024-07-26
Interleukin-mediated therapies in liver diseases and comorbidity effects
Browse: 318   Download: 698   Issue Date: 2024-07-26
Roles of transforming growth factor-β signaling in liver disease
Browse: 350   Download: 613   Issue Date: 2024-07-26
Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature
Browse: 282   Download: 715   Issue Date: 2024-06-27
Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
Browse: 225   Download: 896   Issue Date: 2024-06-27
Importance of the gut microbiota in the gut-liver axis in normal and liver disease
Browse: 211   Download: 553   Issue Date: 2024-06-27
Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
Browse: 206   Download: 510   Issue Date: 2024-06-27